Thomas Wakim
Stock Analyst at Bell Potter
(0.25)
# 4,502
Out of 4,668 analysts
110
Total ratings
39.5%
Success rate
-9.1%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ALC Alcidion Group Limited | Maintained: Buy | $0.15 | $0.09 | +63.04% | 15 | Aug 20, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $120.00 → $150.00 | $166.53 | -9.93% | 11 | Aug 19, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.70 | $3.07 | +20.72% | 7 | Aug 19, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $23.50 → $25.50 | $22.42 | +13.74% | 16 | Aug 6, 2026 | |
| ASX: ATX Amplia Therapeutics Limited | Maintained: Buy | $0.42 | $0.15 | +180.00% | 3 | Aug 5, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.30 | $2.18 | +5.75% | 8 | Jul 30, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.06 | $0.03 | +140.00% | 7 | Jul 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.06 | -12.28% | 13 | Jul 16, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $19.00 → $17.00 | $10.31 | +64.89% | 5 | May 24, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.10 | $0.07 | +47.06% | 8 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.65 → $0.07 | $0.05 | +32.08% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.09 → $0.10 | $0.02 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
Alcidion Group Limited
Aug 20, 2026
Maintained: Buy
Price Target: $0.15
Current: $0.09
Upside: +63.04%
CSL Limited
Aug 19, 2026
Maintained: Hold
Price Target: $120.00 → $150.00
Current: $166.53
Upside: -9.93%
Cogstate Limited
Aug 19, 2026
Maintained: Buy
Price Target: $3.70
Current: $3.07
Upside: +20.72%
Neuren Pharmaceuticals Limited
Aug 6, 2026
Maintained: Buy
Price Target: $23.50 → $25.50
Current: $22.42
Upside: +13.74%
Amplia Therapeutics Limited
Aug 5, 2026
Maintained: Buy
Price Target: $0.42
Current: $0.15
Upside: +180.00%
PYC Therapeutics Limited
Jul 30, 2026
Maintained: Buy
Price Target: $2.30
Current: $2.18
Upside: +5.75%
Syntara Limited
Jul 28, 2026
Maintained: Buy
Price Target: $0.06
Current: $0.03
Upside: +140.00%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.06
Upside: -12.28%
Clinuvel Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $19.00 → $17.00
Current: $10.31
Upside: +64.89%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.07
Upside: +47.06%
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.05
Upside: +32.08%
May 13, 2025
Maintained: Hold
Price Target: $0.09 → $0.10
Current: $0.02
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a